[Multicentre clinical trials: degree of homogeneity in the ethical-scientific review performed by research ethics committees].
Dal-Ré
Rafael
R
Departamento Médico, GlaxoSmithKline S.A., Tres Cantos, Madrid, Spain. rafael.dal-re@gsk.com
Pedromingo
Alejandro
A
Morejón
Elena
E
Luque
Isabel
I
D019380:Anti-HIV Agents / Q000627:therapeutic use; D002219:Carbamates; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000941:ethics*; D017326:Clinical Trials, Phase III as Topic; D032962:Consent Forms; D028744:Ethics Committees, Research; D005663:Furans; D006801:Humans; D015337:Multicenter Studies as Topic / Q000941:ethics*; D010755:Organophosphates / Q000627:therapeutic use; D013030:Spain; D013449:Sulfonamides / Q000627:therapeutic use
D019380:Anti-HIV Agents; D002219:Carbamates; D005663:Furans; D010755:Organophosphates; D013449:Sulfonamides; C426859:fosamprenavir